CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Option exercise Director acquired 5,938 shares (option exercise)
- 4 Option exercise Director acquired 4,843 shares (option exercise)
- 4 Option exercise Director acquired 8,438 shares (option exercise)
- 4 Option exercise Director acquired 5,000 shares (option exercise)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Bylaws or fiscal year change
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 3 Insider Initial Statement of Ownership
- D Other Notice of Sales of Unregistered Securities
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale · Other events
- 4 Derivatives Options or other derivatives
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Delisting notice
- RW Other RW
Page 6 of 78 · 1,549 filings